High-Power Short-Duration Radiofrequency Ablation in Patients With Typical Atrial Flutter

NCT ID: NCT05777850

Last Updated: 2023-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-25

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of cavotricuspid isthmus (CTI) dependent flutter ablation is the bidirectional conduction block of CTI. The probability of achieving a permanent bidirectional block at the CTI depends, mainly, on the ablation energy applied and the quality of the obtained lesion. Among the factors that determine the lesion's quality those which have the bigger impact are catheter stability, contact force, power and duration of energy application and the temperature reached at depth.This is a multicenter 1:1 randomized, blinded (open for the operator) study. Two CTI ablation strategies are compared: 1) conventional treatment branch which consists of individual 25-40 W applications of unlimited duration until achieving in each application the minimum value of one of the currently accepted and used lesion markers (Ablation Index \>500 at the anterior half of the CTI and \>400 at the posterior half with de CARTO 3 system; 2) experimental treatment branch consistent of CTI block using individual high power (90W) short duration (4 seconds) point-by-point applications. The main objective of this study is assessing the non-inferiority of the efficacy and safety of high-power short-duration ablation in patients undergoing typical atrial flutter ablation. Secondary objectives include the comparison of total radiofrequency time, number of applications, number of steam pops, percentage of reconnections, procedure duration, pain during the procedure and time to atrial flutter recurrence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Typical Atrial Flutter Catheter Ablation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional ablation

CTI ablation with electroanatomic navigation system using individual 25-40 W applications of unlimited duration until achieving in each application the minimum value of one of the currently accepted and used lesion markers: Ablation Index \>500 at the anterior half of the CTI and \>400 at the posterior half with de CARTO 3 system. Minimum contact force required is 5 grams. Maximum distance between applications must be 6 mm.

Group Type ACTIVE_COMPARATOR

Conventional cavotricuspid isthmus ablation

Intervention Type PROCEDURE

Point-by-point 25-40 W applications at the CTI of unlimited duration until achieving the pre-established Ablation Index.

High-power short-duration ablation

CTI ablation with electroanatomic navigation system using individual high power (90W) short duration (4 seconds) applications in a catheters' stable position with a minimum contact force of 15-30 g at the anterior half and 10-25 g at the posterior one. Maximum distance between applications is settled at 4 mm.

Group Type EXPERIMENTAL

High-power short-duration ablation

Intervention Type PROCEDURE

Point-by-point 90W applications at the CTI ablation during 4 seconds.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conventional cavotricuspid isthmus ablation

Point-by-point 25-40 W applications at the CTI of unlimited duration until achieving the pre-established Ablation Index.

Intervention Type PROCEDURE

High-power short-duration ablation

Point-by-point 90W applications at the CTI ablation during 4 seconds.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with cavotricuspid isthmus dependent flutter referred to ablation
* Patients clinically and hemodynamically stable.
* Patients who give informed consent.

Exclusion Criteria

* Refusal to participate in the register or inability to understand the informed consent.
* Age under 18.
* Patients who have already undergone previous flutter ablation procedures.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jose Luis Ibañez Criado

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jose Luis Ibañez Criado

Medical Doctor

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital General Doctor Balmis Alicante

Alicante, A, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Laura Valverde Soria

Role: CONTACT

687198597

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Laura Valverde Soria

Role: primary

+34687198597

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Valverde Soria L, Toquero J, Brouzet T, Garcia Cano L, Garcia Barrios A, Segura Dominguez M, Hermon Ramirez GA, Ajo Ferrer R, Ajo Ferrer M, Andreu Concha CM, Arrarte Esteban V, Sanchez Barbie A, Martinez-Martinez JG, Ibanez Criado A, Ibanez Criado JL. Very high-power short-duration radiofrequency ablation in patients with typical atrial flutter: rationale and design of the FASD-HP randomized trial. J Interv Card Electrophysiol. 2025 Apr;68(3):497-503. doi: 10.1007/s10840-024-01969-7. Epub 2024 Dec 21.

Reference Type DERIVED
PMID: 39708245 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FASD-HP trial

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.